Share on StockTwits

Cytosorbents Corp (NASDAQ:CTSO) Director James T. Gunton sold 1,360,000 shares of the stock on the open market in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $0.24, for a total value of $326,400.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Separately, analysts at HC Wainwright initiated coverage on shares of Cytosorbents Corp in a research note on Monday, August 18th. They set a “buy” rating and a $1.00 price target on the stock.

Shares of Cytosorbents Corp (NASDAQ:CTSO) traded down 1.25% on Thursday, hitting $0.237. The stock had a trading volume of 1,010,611 shares. Cytosorbents Corp has a 52 week low of $0.09 and a 52 week high of $0.35. The stock’s 50-day moving average is $0.25 and its 200-day moving average is $0.24. The company’s market cap is $73.6 million.

Cytosorbents Corp (NASDAQ:CTSO) last released its earnings data on Tuesday, August 12th. The company reported ($0.01) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.01). Analysts expect that Cytosorbents Corp will post $-0.03 EPS for the current fiscal year.

CytoSorbents Corporation is a development stage critical care focused company using blood purification to treat life-threatening illnesses.

Receive News & Ratings for Cytosorbents Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytosorbents Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.